Delex Healthcare Group Inc. (OTCPK: DELX)
Health Care · Pharmaceuticals · PH
$0.01
-6.67% today · -22.2% 1Y
Delex Healthcare Group Inc. (OTCPK: DELX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.20M and employs 149 people.
Over the last twelve months the share price has lost 22.2%, trading between 0.00 and 0.01.
Tweenvest scores Delex Healthcare Group Inc. across four factors: value 70/100. Its strongest factor is value.
DELX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.20M
- Revenue (TTM)
- $7.26M
- P/E
- 5.38
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 600.00M
- Employees
- 149
- Next earnings
- —
About Delex Healthcare Group Inc.
Delex Healthcare Group, Inc. engages in the provision of asset management and consultancy services. The company was founded in January 1990 and is headquartered in Taguig, Metro Manila.
- Founded
- 2017
- Listed since
- Mar 14, 1996
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.